Molecular genetics of multiple endocrine neoplasia types 1 and 2. (Q36111935)

12 August 2017

1 reference

title

Molecular genetics of multiple endocrine neoplasia types 1 and 2. (English)

1 reference

multiple endocrine neoplasia

12 August 2017

1 reference

1 reference

Stephen J Marx

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

12 August 2017

published in

Nature Reviews Cancer

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

5

1 reference

12 August 2017

page(s)

367-375

1 reference

Stable overexpression of MEN1 suppresses tumorigenicity of RAS.

12 August 2017

cites work

1 reference

Transfection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of JunD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/

21 January 2018

1 reference

Gene dose mapping delineated boundaries of a large germline deletion responsible for multiple endocrine neoplasia type 1.

21 January 2018

1 reference

Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors

21 January 2018

1 reference

A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors

21 January 2018

1 reference

Of mice and MEN1: Insulinomas in a conditional mouse knockout

21 January 2018

1 reference

Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1.

21 January 2018

1 reference

Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs.

21 January 2018

1 reference

Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues

21 January 2018

1 reference

Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma

21 January 2018

1 reference

The discovery of receptor tyrosine kinases: targets for cancer therapy

21 January 2018

1 reference

Oncogenic kinase signalling

21 January 2018

1 reference

Minireview: RET: normal and abnormal functions

21 January 2018

1 reference

Genomic variation in multigenic traits: Hirschsprung disease.

21 January 2018

1 reference

A Novel Germ-Line Point Mutation in RET Exon 8 (Gly533Cys) in a Large Kindred with Familial Medullary Thyroid Carcinoma

21 January 2018

1 reference

V804M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriers

21 January 2018

1 reference

Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition

21 January 2018

1 reference

Early Malignant Progression of Hereditary Medullary Thyroid Cancer

21 January 2018

1 reference

Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation

21 January 2018

1 reference

A human yeast artificial chromosome containing the multiple endocrine neoplasia type 2B Ret mutation does not induce medullary thyroid carcinoma but does support the growth of kidneys and partially rescues enteric nervous system development in Ret-d

21 January 2018

1 reference

C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B

21 January 2018

1 reference

A census of human cancer genes

21 January 2018

1 reference

The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors

21 January 2018

1 reference

Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia

21 January 2018

1 reference

Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma.

21 January 2018

1 reference

Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma

21 January 2018

1 reference

Menin, the product of the MEN1 gene, is a nuclear protein

21 January 2018

1 reference

Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription

21 January 2018

1 reference

Identification and characterization of JunD missense mutants that lack menin binding

21 January 2018

1 reference

Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter

21 January 2018

1 reference

Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus

21 January 2018

1 reference

Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression

21 January 2018

1 reference

Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis

21 January 2018

1 reference

Mechanisms of transformation by MLL.

21 January 2018

1 reference

Multiple tumor suppressor pathways negatively regulate telomerase

21 January 2018

1 reference

Menin induces apoptosis in murine embryonic fibroblasts

21 January 2018

1 reference

Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1.

21 January 2018

1 reference

RET and neuroendocrine tumors

21 January 2018

1 reference

Evaluation of germline sequence variants of GFRA1, GFRA2, and GFRA3 genes in a cohort of Spanish patients with sporadic medullary thyroid cancer

21 January 2018

1 reference

A model for GFR alpha 4 function and a potential modifying role in multiple endocrine neoplasia 2.

21 January 2018

1 reference

Identification of RET autophosphorylation sites by mass spectrometry

21 January 2018

1 reference

Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors

21 January 2018

1 reference

Chemical genomic profiling to identify intracellular targets of a multiplex kinase inhibitor.

21 January 2018

1 reference

Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes

21 January 2018

1 reference

Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity

21 January 2018

1 reference

Protein kinase inhibitors: insights into drug design from structure.

21 January 2018

1 reference

Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families

21 January 2018

1 reference

Familial Medullary Thyroid Carcinoma: Clinical Variability and Low Aggressiveness Associated with RET Mutation at Codon 804

21 January 2018

1 reference

Hereditary hormone excess: genes, molecular pathways, and syndromes

21 January 2018

1 reference

Somatic mutation of the MEN1 gene in parathyroid tumours

31 March 2020

1 reference

Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory.

31 March 2020

1 reference

Familial Somatotropinomas

31 March 2020

1 reference

Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1.

31 March 2020

1 reference

Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1

31 March 2020

1 reference

Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia, type I

31 March 2020

1 reference

The RET receptor: function in development and dysfunction in congenital malformation

31 March 2020

1 reference

TTF-1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung's disease

31 March 2020

1 reference

Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells

31 March 2020

1 reference

Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation

31 March 2020

1 reference

Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation

31 March 2020

1 reference

Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804.

31 March 2020

1 reference

Premature centromere division in patients with multiple endocrine neoplasia type 1

31 March 2020

1 reference

Quantitative phenotyping as an efficient means to estimate C-cell number in a knock-in mouse model of MEN2B

31 March 2020

1 reference

Hereditary cancer: two hits revisited

31 March 2020

1 reference

Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma

31 March 2020

1 reference

Menin molecular interactions: insights into normal functions and tumorigenesis.

31 March 2020

1 reference

The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene

31 March 2020

1 reference

Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.

31 March 2020

1 reference

Molecular mechanisms of RET activation in human cancer.

31 March 2020

1 reference

The RET receptor is linked to stress response pathways

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1610

1 reference

12 August 2017

1 reference